The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a Machine Learning Approach

被引:15
作者
Bevacqua, Emilia [1 ]
Ammirato, Salvatore [2 ]
Cione, Erika [1 ]
Curcio, Rosita [1 ]
Dolce, Vincenza [1 ]
Tucci, Paola [1 ]
机构
[1] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, Italy
[2] Univ Calabria, Dept Mech Energy & Management Engn, I-87036 Arcavacata Di Rende, Italy
关键词
tumor; microRNA; biomarker; prognosis; text mining; digitalization; PREDICT BIOCHEMICAL RECURRENCE; BLOOD MONONUCLEAR-CELLS; CIRCULATING MICRORNAS; EXPRESSION LEVELS; DOWN-REGULATION; PROGRESSION; MIRNAS; SERUM; PROMOTES; MIR-375;
D O I
10.3390/cancers14215418
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Prostate cancer (PCa) is the most common cancer in men worldwide. Screening and diagnosis are based on prostate-specific antigen (PSA) blood testing and digital rectal examination. Nevertheless, these methods are not specific and have a high risk of mistaken results. This has led to overtreatment and unnecessary radical therapy; thus, better prognostic tools are urgently needed. In this view, microRNAs (miRs) appear as potential non-invasive biomarkers for PCa diagnosis, prognosis, and therapy. As the scientific literature available in this field is huge and very often controversial, we identified and discussed three topics that characterize the investigated research area by combining the big data from the literature together with a novel machine learning approach. By analyzing the papers clustered into these topics we have offered a deeper understanding of the current research, which helps to contribute to the advancement of this research field. Background: Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men. Although the prostate-specific antigen (PSA) test is used in clinical practice for screening and/or early detection of PCa, it is not specific, thus resulting in high false-positive rates. MicroRNAs (miRs) provide an opportunity as biomarkers for diagnosis, prognosis, and recurrence of PCa. Because the size of the literature on it is increasing and often controversial, this study aims to consolidate the state-of-art of relevant published research. Methods: A Systematic Literature Review (SLR) approach was applied to analyze a set of 213 scientific publications through a text mining method that makes use of the Latent Dirichlet Allocation (LDA) algorithm. Results and Conclusions: The result of this activity, performed through the MySLR digital platform, allowed us to identify a set of three relevant topics characterizing the investigated research area. We analyzed and discussed all the papers clustered into them. We highlighted that several miRs are associated with PCa progression, and that their detection in patients' urine seems to be the more reliable and promising non-invasive tool for PCa diagnosis. Finally, we proposed some future research directions to help future scientists advance the field further.
引用
收藏
页数:24
相关论文
共 123 条
[1]   MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer [J].
Aghdam, Arad Mobasher ;
Amiri, Atefeh ;
Salarinia, Reza ;
Masoudifar, Aria ;
Ghasemi, Faezeh ;
Mirzaei, Hamed .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2019, 29 (02) :127-139
[2]   Circulating microRNA signature for the diagnosis of very high-risk prostate cancer [J].
Alhasan, Ali H. ;
Scott, Alexander W. ;
Wu, Jia J. ;
Feng, Gang ;
Meeks, Joshua J. ;
Thaxton, C. Shad ;
Mirkin, Chad A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (38) :10655-10660
[3]   microRNA-141 as a diagnostic and prognostic biomarker for prostate cancer in Egyptian population: Pilot study [J].
Ali, R. ;
El Tabbakh, S. ;
El Delgawy, W. ;
Kotb, A. ;
Desouky, M. N. .
AFRICAN JOURNAL OF UROLOGY, 2018, 24 (04) :347-352
[4]   Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study [J].
Alshalalfa, Mohammed ;
Bader, Gary D. ;
Goldenberg, Anna ;
Morris, Quaid ;
Alhajj, Reda .
BMC SYSTEMS BIOLOGY, 2012, 6
[5]   Digitalising the Systematic Literature Review process: the MySLR platform [J].
Ammirato, Salvatore ;
Felicetti, Alberto M. ;
Rogano, Daniele ;
Linzalone, Roberto ;
Corvello, Vincenzo .
KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE, 2023, 21 (04) :777-794
[6]   MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases [J].
Arora, Sumit ;
Saini, Sharanjot ;
Fukuhara, Shinichiro ;
Majid, Shahana ;
Shahryari, Varahram ;
Yamamura, Soichiro ;
Chiyomaru, Takeshi ;
Deng, Guoren ;
Tanaka, Yuichiro ;
Dahiya, Rajvir .
PLOS ONE, 2013, 8 (11)
[7]   An androgen-regulated miR-2909 modulates TGFβ signalling through AR/miR-2909 axis in prostate cancer [J].
Ayub, Shiekh Gazalla ;
Kaul, Deepak ;
Ayub, Taha .
GENE, 2017, 631 :1-9
[8]   Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis [J].
Barcelo, Maria ;
Castells, Manel ;
Bassas, Lluis ;
Vigues, Francesc ;
Larriba, Sara .
SCIENTIFIC REPORTS, 2019, 9 (1)
[9]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[10]   Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer [J].
Basu, Sanmitra ;
Chaudhary, Amrita ;
Chowdhury, Pramita ;
Karmakar, Deepmala ;
Basu, Keya ;
Karmakar, Dilip ;
Chatterjee, Jyotirmoy ;
Sengupta, Sanghamitra .
GENE, 2020, 730